VVY.AS
Price:
$1.61
Market Cap:
$41.97M
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a small molecule QC inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease; and for the treatment of cancer. Its preclinical development product is PQ1565, a small molecule glutaminyl-peptide cyclotransferase-like inhibitor for the treatment of cancer. In addition, the company is developing a monoclonal antibody...[Read more]
Industry
Biotechnology
IPO Date
2014-10-27
Stock Exchange
AMS
Ticker
VVY.AS
According to Vivoryon Therapeutics N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 37.20M. This represents a change of -48.94% compared to the average of 72.86M of the last 4 quarters.
The mean historical Enterprise Value of Vivoryon Therapeutics N.V. over the last ten years is 139.10M. The current 37.20M Enterprise Value has changed 2.57% with respect to the historical average. Over the past ten years (40 quarters), VVY.AS's Enterprise Value was at its highest in in the December 2021 quarter at 366.52M. The Enterprise Value was at its lowest in in the June 2011 quarter at 0.
Average
139.10M
Median
145.65M
Minimum
21.01M
Maximum
365.56M
Discovering the peaks and valleys of Vivoryon Therapeutics N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 467.10%
Maximum Annual Enterprise Value = 365.56M
Minimum Annual Increase = -77.21%
Minimum Annual Enterprise Value = 21.01M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 42.55M | -77.21% |
| 2023 | 186.69M | -7.03% |
| 2022 | 200.82M | -45.07% |
| 2021 | 365.56M | 137.40% |
| 2020 | 153.99M | 467.10% |
| 2019 | 27.15M | 29.25% |
| 2018 | 21.01M | -76.02% |
| 2017 | 87.61M | -36.20% |
| 2016 | 137.32M | -18.41% |
| 2015 | 168.30M | 84.39% |
The current Enterprise Value of Vivoryon Therapeutics N.V. (VVY.AS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
143.35M
5-year avg
189.92M
10-year avg
139.10M
Vivoryon Therapeutics N.V.’s Enterprise Value is less than Avantium N.V. (201.40M), less than B&S Group S.A. (890.27M), less than Marinomed Biotech AG (44.26M), less than Pharming Group N.V. (1.12B), less than Ryvu Therapeutics S.A. (657.54M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 201.40M | $60.11M | |
| 890.27M | $500.86M | |
| 44.26M | $35.03M | |
| 1.12B | $966.06M | |
| 657.54M | $691.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vivoryon Therapeutics N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vivoryon Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vivoryon Therapeutics N.V.'s Enterprise Value?
What is the highest Enterprise Value for Vivoryon Therapeutics N.V. (VVY.AS)?
What is the 3-year average Enterprise Value for Vivoryon Therapeutics N.V. (VVY.AS)?
What is the 5-year average Enterprise Value for Vivoryon Therapeutics N.V. (VVY.AS)?
How does the current Enterprise Value for Vivoryon Therapeutics N.V. (VVY.AS) compare to its historical average?